IBDoc Regulatory Approval

New Smartphone Models Supported

In September we received regulatory approval to expand the list of supported smartphones for IBDoc®.  Like for the previous approvals, we used our established thorough validation control to add 12 additional models. Since each smartphone model differs in camera and processor type, which relates to differences in measurement we always need to make sure that the supported

Continue Reading →

New Supported Smartphones

In December we received regulatory approval to expand the list of supported smartphones for IBDoc. To achieve this we established a thorough validation control to be able to include new smartphones. Since each smartphone model differs in camera and processor type, which relates to differences in measurement we always need to make sure that the supported

Continue Reading →
IBDoc in Australia

IBDoc TGA approved for Australia

IBDoc® is now available in Australia. IBDoc® achieved the CE certification in April 2015 for self-testing making it available to patients throughout Europe. Now a second major milestone has been reached. The Australian Health Authorities TGA (Therapeutic Goods Administration), approved the use of IBDoc®. This means that IBDoc® can now be made available to all Australian IBD patients

Continue Reading →

BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test

Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a  CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis

Continue Reading →